I in vitro- undersøgelser blev det fastslået, at daptomycin hverken hæmmer eller fremkalder klinisk signifikant aktivitet i humane CYP- isoformer (lA2, 2A6, 2C9, 2C19, 2D6, 2E1, 3A4).
In vitro studies have determined that daptomycin does not inhibit or induce the activities of clinically significant human CYP isoforms (1A2, 2A6, 2C9, 2C19, 2D6, 2E1, 3A4).